Fournier, C. (2023) “Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients”, Canadian Dermatology Today. Toronto, Canada, 4(3), pp. 5–10. Available at: https://canadiandermatologytoday.com/article/view/4-3-fournier (Accessed: 14 August 2024).